Induced Pluripotent Stem Cell (iPSC) Market - By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic, Others), By Application (Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Gene & Cell Therapy), By End-User (Hospitals, Research Laboratories) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 268 | Published : July 2021 | SKU CODE : o&s282 | Format :

Request Sample

Induced Pluripotent Stem Cell (iPSC) Market Definition

The induced pluripotent stem cell (iPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as hepatocytes, fibroblasts, keratinocytes, and neurons.

Induced pluripotent stem cell (iPSC) are derived from somatic cells such as skin or blood cells that have been reprogrammed, by ectopic introduction of transcriptional factor genes, back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes.

Induced Pluripotent Stem Cell (iPSC) Market Size

The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,223.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 9.2% since 2015. The market is expected to grow from $2,223.5 million in 2020 to $3,362.1 million in 2025 at a rate of 8.6%. The induced pluripotent stem cell (iPSC) market is then expected to grow at a CAGR of 6.2% from 2025 and reach $4,547.7 million in 2030.  

Growth in the historic period resulted from increased healthcare spending, rise in funding, aid as non – animal alternatives for preclinical trials and increasing demand of personalized medicines. Factor that negatively affected growth in the historic period was lack of awareness on induced pluripotent stem cell.

Going forward, increasing prevalence of chronic diseases, growth genomic projects, development in iPSC models, increasing funding and increasing prevalence of genetic diseases. Factors that could hinder the growth of the induced pluripotent stem cell (iPSC) market in the future include risk associated with it and high costs associated with storage.

Induced Pluripotent Stem Cell (iPSC) Market Drivers

The key drivers of the induced pluripotent stem cell (iPSC) market include:

Increasing Prevalence Of Chronic Diseases

Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of Induced pluripotent stem cell market. Chronic disorders like heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell. Induced Pluripotent stem cells are taken from any tissues from a child or an adult and are genetically modified to behave like embryonic stem cells. According to the report published by Partnership to Fight Chronic Disorder (PFCD), it was found that out of 133 Million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is expected to drive the demand for induced pluripotent stem cell treatment in the forecast period.

Induced Pluripotent Stem Cell (iPSC) Market Restraints

The key restraints on the induced pluripotent stem cell (iPSC) market include:

The Risk Associated With Induced Pluripotent Stem Cell Treatment

The potential risk of tumor is one of the major restraints on the growth of Induced pluripotent stem cell market. As per scientific research, it was found that there might be a chance of getting cancer from the treatment and people are unwilling to take treatment through induced pluripotent stem cell therapy. According to the report by American Association for cancer research, in most of the cases during an experiment it was found that the occurrence of the tumors was prevalent after a short period of time. This risk of developing a tumor due to Induced pluripotent stem cell therapy is limiting the number of patients opting for this treatment, thereby can restrain the growth of the market in the forecast period.

Induced Pluripotent Stem Cell (iPSC) Market Trends

Major trends influencing the induced pluripotent stem cell (iPSC) market include:

Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)

Extensive research is being conducted on the use of induced pluripotent stem cells to treat Parkinson’s disease (PD). Parkinson’s disease (PD) is a neurodegenerative disorder that affects nerve cells involved in releasing dopamine. The reprogramming of mature cells from skin into induced pluripotent nerve cells which can produce dopamine can be a potential treatment for the Parkinson’s disease (PD). In 2018, researchers from Kyoto University, Japan transplanted iPSC’s into the brain of patient with Parkinson’s disease (PD) which will act as precursors for nerve cells to produce dopamine.

Strategic Collaborations And Partnerships

Major companies operating in the induced pluripotent stem cell (iPSC) market are undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market.  Companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, and in or out-licensing deals. For instance, in November 2020, FUJIFILM Cellular Dynamics, Inc., a US based developer and manufacturer of human induced pluripotent stem cells (iPSCs) announced that it has entered into a worldwide agreement with Lonza Walkersville, Inc., a US based GMP iPSC manufacturer. With the partnership, FUJIFILM Cellular Dynamics grants Lonza a non-exclusive right to use their patents related to iPSC generation and Lonza grants FUJIFILM Cellular Dynamics expanded use of its non-exclusive license to its innovative Nucleofector™ technology and leverage both companies’ expertise and technologies for the generation of human-induced pluripotent stem cells through licensing agreements. In October 2020, Insitro, Inc., a US based data-driven drug discovery and development company entered into a five-year collaboration with Bristol Myers Squibb to develop treatments for neurodegenerative disorders. Through this collaboration, insitro will use its insitro Human (ISH) platform to build induced pluripotent stem cell (iPSC) derived disease models for ALS and FTD. Bristol Myers Squibb is a US based pharmaceuticals company that manufactures prescription pharmaceuticals and biologics in several therapeutic areas.

Opportunities And Recommendations In The Induced Pluripotent Stem Cell (iPSC) Market

Opportunities –The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by derived cell type will arise in the fibroblasts segment, which will gain $360.1 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by end-user industry will arise in the hospitals segment, which will gain $393.0 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by application will arise in the drug discovery and toxicity studies segment, which will gain $520.3 million of global annual sales by 2025. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $132.6 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the induced pluripotent and stem cell companies to consider investing in induced pluripotent stem cells, which have proved to be efficient in various diseases for disease modelling and gene therapy, and focus on the acquisitions of mid-size and small companies which are technologically advanced to help increase production capacity and expand product portfolio, focus on securing long-term supply contracts with significant healthcare institutions to provide the patients with quality products, companies should consider offering value-based pricing for their induced pluripotent stem cells, as stakeholders would want to evaluate both the short- and long-term benefits of the product’s value, while hospitals and surgeons focus on the quality and features of the system and after-sales services, companies should expand their business in emerging markets to increase awareness in emerging markets which results in increasing demand for induced pluripotent stem cells, among other strategies.

Induced Pluripotent Stem Cell (iPSC) Market Segmentation

The induced pluripotent stem cell (iPSC) market is segmented by derived cell type, by application, by end-use industry and by geography.
By Derived Cell Type -
The induced pluripotent stem cell (iPSC) market is segmented by derived cell type into
    • a) Hepatocytes
    • b) Fibroblasts
    • c) Keratinocytes
    • d) Amniotic Cells
    • e) Others
The fibroblasts was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by derived cell type, accounting for 33.0% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by derived cell type, at a CAGR of 10.0% during 2020-2025.
By Application -
The induced pluripotent stem cell (iPSC) market is segmented by application into
    • a) Academic Research
    • b) Drug Discovery And Toxicity Studies
    • c) Cell & Gene Therapy
    • d) Regenerative Medicine
The drug discovery and toxicity studies was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by application, accounting for 48.7% of the total in 2020. Going forward, cell & gene therapy segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by application, at a CAGR of 9.82% during 2020-2025.
By End-User -
The induced pluripotent stem cell (iPSC) market is segmented by end-user into
    • a) Research Laboratories
    • b) Hospitals
The research laboratories was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by end-user, accounting for 68.5% of the total in 2020. Going forward, the hospitals segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by end-user, at a CAGR of 9.3% during 2020-2025.
By Geography- The induced pluripotent stem cell (iPSC) market is segmented by geography into
    • o Asia Pacific
      • • China
      • • Japan
      • • India
      • • Australia
      • • Indonesia
      • • South Korea
    • o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the induced pluripotent stem cell (iPSC) market, accounting for 49.8% of the total in 2020. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the induced pluripotent stem cell (iPSC) market will be Africa and Asia- Pacific.

Induced Pluripotent Stem Cell (iPSC) Competitive Landscape

Major Competitors In The Induced Pluripotent Stem Cell (iPSC) Market Are:

  • Fujifilm Holding Corporation
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • ViaCyte
  • Fate Therapeutics
  • Other Competitors In The Induced Pluripotent Stem Cell (iPSC) Market Include:

  • Horizon Discovery Group
  • Ncardia
  • StemCells
  • Cynata Therapeutics
  • Cell Applications, Inc.
  • Shenzhen Bioscience
  • Dainippon Sumitomo Pharma
  • Shanghai Cell Therapy Group
  • Car-T Bio
  • JW therapeutics
  • Fosun Kite Biotechnology
  • Shanghai UniCar Therapy
  • Cellerix
  • CellGenix
  • NsGene
  • TiGenix
  • Renuron Group
  • Smart Cells
  • Genenta Science
  • Biocad Rf
  • Msd
  • Pfizer
  • Roche
  • Pharmasyntez
  • Selvita
  • Mabion
  • Pure Biologics
  • OncoArendi Therapeutics
  • Proteon Pharmaceuticals
  • GlaxoSmithKline
  • Parexel
  • Bayer
  • Sangamo Therapeutics
  • Athersys
  • BrainStorm Cell Therapeutics
  • Cellular Biomedicine Group
  • Pluristem Therapeutics
  • Gamida Cell
  • VistaGen Therapeutics
  • Caladrius Biosciences
  • ThermoGenesis Holdings
  • BioCanRx
  • CellCAN
  • CCRM
  • C3i
  • BioCells Argentina
  • Banco de Cordon del Peru
  • CryoHoldco
  • CellSave Arabia
  • LifeCell
  • AmiCare
  • Cells4life
  • ReeLabs
  • StemCells
  • Royan Stem Cell Technology Co
  • Next BioSciences
  • CryoSave
  • BioHeart
  • StemCell Technologies
  • NetCells
    1. Table Of Contents

      1. Induced Pluripotent Stem Cell (iPSC) Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Derived Cell Type

      6.3. Segmentation By Application

      6.4. Segmentation By End-Use Industry

      7. Induced Pluripotent Stem Cell (iPSC) Market Characteristics

      7.1. Segmentation By Derived Cell Type

      7.1.1. Hepatocytes

      7.1.2. Fibroblasts

      7.1.3. Keratinocytes

      7.1.4. Amniotic

      7.1.5. Others

      7.2. Segmentation By Application

      7.2.1. Academic Research

      7.2.2. Drug Discovery And Toxicity Studies

      7.2.3. Regenerative Medicine

      7.2.4. Gene & Cell Therapy

      7.3. Segmentation By End-User

      7.3.1. Hospitals

      7.3.2. Research Laboratories

      8. Induced Pluripotent Stem Cell (iPSC) Trends And Strategies

      8.1. Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)

      8.2. Strategic Collaborations And Partnerships

      8.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells

      8.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy

      8.5. Expansion and Improvements in Drug Research

      8.6. Use of Pluripotent Stem Cells in treating Type 1 Diabetes

      9. Impact Of Covid-19 On Induced Pluripotent Stem Cell (iPSC) Market

      9.1. Impact On Demand For Induced Pluripotent Stem Cells

      9.2. Increase In Research And Development Activities

      10. Global Induced Pluripotent Stem Cell (iPSC) Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Induced Pluripotent Stem Cell (iPSC) Segmentation

      11.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type , Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. Fibroblasts

      11.1.2. Hepatocytes

      11.1.3. Keratinocytes

      11.1.4. Amniotic

      11.1.5. Others

      11.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Drug Discovery & Toxicity Studies

      11.2.2. Academic Research

      11.2.3. Cell & Gene Therapy

      11.2.4. Regenerative Medicine

      11.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3.1. Research Laboratories

      11.3.2. Hospitals

      12. Induced Pluripotent Stem Cell (iPSC) Market, Regional And Country Analysis

      12.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market

      13.1. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Impact of COVID-19

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Taxes Levied

      13.1.10. Corporate Tax Structure

      13.1.11. Investments

      13.1.12. Major Companies

      13.2. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      13.7. China Induced Pluripotent Stem Cell (iPSC) Market

      13.8. China Induced Pluripotent Stem Cell (iPSC) Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. Impact of COVID-19

      13.8.4. Background Information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Taxes Levied

      13.8.10. Corporate Tax Structure

      13.8.11. Investments

      13.8.12. Major Companies

      13.9. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.11. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Induced Pluripotent Stem Cell (iPSC) Market

      13.14. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.16. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Induced Pluripotent Stem Cell (iPSC) Market

      13.19. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Induced Pluripotent Stem Cell (iPSC) Market

      13.24. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Induced Pluripotent Stem Cell (iPSC) Market

      13.29. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.30. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. South Korea Induced Pluripotent Stem Cell (iPSC) Market

      13.33. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.34. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Induced Pluripotent Stem Cell (iPSC) Market

      14.1. Western Europe Induced Pluripotent Stem Cell (iPSC) Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Impact Of COVID-19

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      14.7. UK Induced Pluripotent Stem Cell (iPSC) Market

      14.8. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Induced Pluripotent Stem Cell (iPSC) Market

      14.13. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Induced Pluripotent Stem Cell (iPSC) Market

      14.18. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.20. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market

      15.1. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Impact Of COVID-19

      15.1.4. Background information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory bodies

      15.1.8. Major Associations

      15.1.9. Taxes levied

      15.1.10. Corporate tax structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      15.7. Russia Induced Pluripotent Stem Cell (iPSC) Market

      15.8. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Induced Pluripotent Stem Cell (iPSC) Market

      16.1. North America Induced Pluripotent Stem Cell (iPSC) Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. COVID-19 Impact

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Associations

      16.1.9. Taxes Levied

      16.1.10. Corporate Tax Structure

      16.1.11. Investments

      16.1.12. Major Companies

      16.2. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      16.7. USA Induced Pluripotent Stem Cell (iPSC) Market

      16.8. USA Induced Pluripotent Stem Cell (iPSC) Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. COVID-19 Impact

      16.8.4. Background Information

      16.8.5. Government Initiatives

      16.8.6. Regulations

      16.8.7. Regulatory Bodies

      16.8.8. Associations

      16.8.9. Taxes Levied

      16.8.10. Corporate Tax Structure

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Induced Pluripotent Stem Cell (iPSC) Market

      17.1. South America Induced Pluripotent Stem Cell (iPSC) Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. COVID-19 Impact

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis

      17.7. Brazil Induced Pluripotent Stem Cell (iPSC) Market

      17.8. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Induced Pluripotent Stem Cell (iPSC) Market

      18.1. Middle East Induced Pluripotent Stem Cell (iPSC) Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. COVID-19 Impact

      18.1.4. Background information

      18.1.5. Government Initiatives

      18.1.6. Regulations

      18.1.7. Regulatory bodies

      18.1.8. Major Associations

      18.1.9. Taxes levied

      18.1.10. Corporate tax structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Induced Pluripotent Stem Cell (iPSC) Market

      19.1. Africa Induced Pluripotent Stem Cell (iPSC) Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. COVID-19 Impact

      19.1.4. Background information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory bodies

      19.1.8. Major Associations

      19.1.9. Taxes levied

      19.1.10. Corporate tax structure

      19.1.11. Investments

      19.1.12. Major Companies

      19.2. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Induced Pluripotent Stem Cell (iPSC) Competitive Landscape

      20.1. Company Profiles

      20.2. Fujifilm Holdings Corporation

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Thermo Fisher Scientific Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Takara Bio Inc.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. ViaCyte

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Fate Therapeutics

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial overview

      21. Key Mergers And Acquisitions In The Induced Pluripotent Stem Cell (iPSC) Market

      21.1. Axol Bioscience Mergerd With Censo Biotechnologies

      21.2. FUJIFILM Cellular Dynamics Merged with Sana Biotechnology

      21.3. FUJIFILM Cellular Dynamics Collaborated With Lonza Walkersville, Inc.

      21.4. Insitro, Inc. Collaborated With Bristol Myers Squibb

      21.5. Century Therapeutics Acquired of Empirica Therapeutics

      21.6. Fate Therapeutics Collaborated With Janssen

      21.7. Bristol-Myers Squibb Company Collaborated With Evotech

      21.8. Allogene Therapeutics Merged with Notch Therapeutics

      21.9. Bayer Acquired BlueRock Therapeutics

      21.10. Evotech Acquired NCARDIA

      21.11. Evotec AG Merged with Celgene

      21.12. Pluriomics and Axiogenesis Merged to establish Ncardia

      22. Induced Pluripotent Stem Cell (iPSC) Market Opportunities And Strategies

      22.1. Global Induced Pluripotent Stem Cell (iPSC) In 2025 – Countries Offering Most New Opportunities

      22.2. Global Induced Pluripotent Stem Cell (iPSC) In 2025 – Segments Offering Most New Opportunities

      22.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 14: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 15: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Parkinson's Disease, By Country, 2015-2019, Number
    • Table 16: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019
    • Table 17: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 18: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 19: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 20: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 21: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 22: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 23: China Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, 2015-2020, $
    • Table 24: China Induced Pluripotent Stem Cell (iPSC)Market, Population By Age Group, 2015-2025, Thousands
    • Table 25: China Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Parkinson’s Disease, 2015-2019, Number
    • Table 26: China Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019
    • Table 27: China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 28: China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 29: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 30: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 31: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 32: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 33: India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 34: India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 35: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 36: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 37: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 38: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 39: Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 40: Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 41: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 42: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 43: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 44: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 45: Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 46: Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 47: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 48: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 49: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 50: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 51: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 52: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 53: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 54: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 55: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 56: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 57: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 58: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 59: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 60: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 61: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 62: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 63: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 64: Western Europe Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Parkinson's Disease, By Country, 2015-2019, Number
    • Table 65: Western Europe Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019, Number
    • Table 66: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 67: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 68: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 69: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 70: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 71: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 72: UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 73: UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 77: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 78: Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 79: Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 80: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 81: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 82: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 83: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 84: France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 85: France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 86: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 89: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 90: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 91: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 92: Eastern Europe Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Parkinson's disease, By Country, 2015-2019, Number
    • Table 93: Eastern Europe Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019, Number
    • Table 94: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 95: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 96: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 97: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 98: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 99: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 100: Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 101: Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 105: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 106: North America Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 107: North America Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 108: North America Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Parkinson's Disease, By Country, 2015-2019, Number
    • Table 109: North America Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019, Number
    • Table 110: North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 111: North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 112: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 113: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 114: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 115: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 116: USA Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, 2015-2020, $
    • Table 117: USA Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, 2015-2025, Thousands
    • Table 118: USA Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Neurological Diseases, 2015-2019, Number
    • Table 119: USA Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019, Number
    • Table 120: USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 121: USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 122: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 123: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 124: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 125: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 126: South America Induced Pluripotent Stem Cell (IPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 127: South America Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 128: South America Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Parkinson's Disease, By Country, 2015-2019, Number
    • Table 129: South America Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019, Number
    • Table 130: South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 131: South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 132: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 133: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 134: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 135: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 136: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 137: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 138: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 139: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 140: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 141: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 142: Middle East Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 143: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 144: Middle East Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Parkinson's Disease, By Country, 2015-2019, Number
    • Table 145: Middle East Induced Pluripotent Stem Cell (IPSC) Market, Prevalence Of Chronic Kidney Disease, 2015-2019, Number
    • Table 146: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Table 147: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 148: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 149: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 150: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 151: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 152: Africa Induced Pluripotent Stem Cell (iPSC) Market, GDP Per Capita, By Country, 2015-2020, $
    • Table 153: Africa Induced Pluripotent Stem Cell (iPSC) Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 154: Africa Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Parkinson's Disease, By Country, 2015-2019, Number
    • Table 155: Africa Induced Pluripotent Stem Cell (iPSC) Market, Prevalence Of Chronic Kidney Disease, By Country, 2015-2019, Number
    • Table 156: Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 157: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 158: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 159: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 160: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 161: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 162: Fujifilm Holding Corporation – Financial Performance, 2015 – 2019, $ Billion
    • Table 163: Thermo Fisher Scientific Inc.– Financial Performance, 2016 – 2020, $ Billion
    • Table 164: Takara Bio Inc. –  Financial Performance, 2016 – 2020, $ Billion
    • Table 165: Fate Therapeutics  –  Financial Performance, 2016 – 2020, $ Million
    • Table 166: Global Induced Pluripotent Stem Cell (iPSC) Size Gain ($ Million), 2020 – 2025, By Country
    • Table 167: Global Induced Pluripotent Stem Cell (iPSC) Size Gain ($ Million), Segmentation By Derived Cell Type , 2020 – 2025
    • Table 168: Global Induced Pluripotent Stem Cell (iPSC) Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 169: Global Induced Pluripotent Stem Cell (iPSC) Size Gain ($ Million), Segmentation By End-Use Industry, 2020 – 2025
    • Table 170: Induced Pluripotent Stem Cell (iPSC) - Market Data Sources

    List Of Figures

      Figure 1: Global Induced Pluripotent Stem Cell (iPSC) Segmentation By Derived Cell Type
    • Figure 2: Global Induced Pluripotent Stem Cell (iPSC) Segmentation By Application
    • Figure 3: Global Induced Pluripotent Stem Cell (iPSC) Segmentation By End-Use Industry
    • Figure 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: China Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 16: China Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: India Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 20: India Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 32: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 33: Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 35: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 39: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 40: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: UK Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 43: UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 45: UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 47: Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 49: Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: France Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 51: France Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 52: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 55: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 59: Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 60: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 61: Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: North America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 63: North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 64: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: USA Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 67: USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 68: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 69: USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: South America Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 71: South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 72: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 73: South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 75: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 76: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 77: Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic, 2015 – 2020, $ Million
    • Figure 79: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 80: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 83: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 84: Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 85: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 86: Fujifilm Holding Corporation – Financial Performance, 2015 – 2019, $ Billion
    • Figure 87: Thermo Fisher Scientific Inc.– Financial Performance, 2016 – 2020, $ Billion
    • Figure 88: Takara Bio Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 89: Fate Therapeutics – Financial Performance, 2016 – 2020, $ Million
    Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Acne Drugs Market - By Type (Non-Inflammatory Acne Drugs, Inflammatory Acne Drugs), By End-User (Hospitals And Clinics, Others), By Therapeutic Class (Retinoids, Antibiotics, Salicylice) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Cell And Gene Therapy Market - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    HIV Drugs Market - By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Others ) By Application (Hospital Pharmacies, Retail Pharmacies, Others) By Administration (Oral, Parenteral) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Microbiome Market - By Type (Microbial Drugs, Fecal Microbiota Transplantation), By Application (Infectious Diseases, Cancers, Gastrointestinal Disorders, Metabolic Diseases and Others), By End User (Human Therapeutics, Human Diagnostics, Agriculture & Environmental, Food & Feed, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Rituximab Biosimilars Market - By Application (Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Mail Orders) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Induced Pluripotent Stem Cell (IPSC) Global Market Report 2021 - By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells), By Application (Academic Research, Drug Development And Discovery, Toxicity Screening, Regenerative Medicine), By End-User (Hospitals, Research Laboratories), COVID-19 Growth And Change
    View Report
    Pharmaceutical Drugs And Biologics Logistics Market - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)